Edwards Lifesciences News (NYSE:EW)

DateTimeSource
Headline
04/19/20178:30AMPRNUSEdwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance
Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance PR Newswire IRVINE, Calif., April 19, 2017 IRVINE, Calif., April 19, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, has... More...>>
04/10/20177:05AMPRNUSEdwards Lifesciences To Host Earnings Conference Call On April 25, 2017
Edwards Lifesciences To Host Earnings Conference Call On April 25, 2017 PR Newswire IRVINE, Calif., April 10, 2017 IRVINE, Calif., April 10, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans... More...>>
03/09/20176:35AMPRNUSGerman Patent Court Issues Initial Decision
German Patent Court Issues Initial Decision PR Newswire IRVINE, Calif., March 9, 2017 IRVINE, Calif., March 9, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that a district court... More...>>
03/03/20176:50AMPRNUSUK Patent Court Issues Initial Decision
UK Patent Court Issues Initial Decision PR Newswire IRVINE, Calif., March 3, 2017 IRVINE, Calif., March 3, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the Patents Court... More...>>
02/01/20174:15PMPRNUSEdwards Lifesciences Reports Fourth Quarter Results
Edwards Lifesciences Reports Fourth Quarter Results PR Newswire IRVINE, Calif., Feb. 1, 2017 IRVINE, Calif., Feb. 1, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results... More...>>
01/23/20174:15PMPRNUSEdwards Lifesciences Completes Acquisition Of Valtech Cardio
Edwards Lifesciences Completes Acquisition Of Valtech Cardio PR Newswire IRVINE, Calif., Jan. 23, 2017 IRVINE, Calif., Jan. 23, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that... More...>>
01/17/201710:05AMPRNUSEdwards Lifesciences To Host Earnings Conference Call On February 1, 2017
Edwards Lifesciences To Host Earnings Conference Call On February 1, 2017 PR Newswire IRVINE, Calif., Jan. 17, 2017 IRVINE, Calif., Jan. 17, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans... More...>>
01/03/20172:10PMPRNUSEdwards Lifesciences To Present At The 35th Annual J.P. Morgan Healthcare Conference
Edwards Lifesciences To Present At The 35th Annual J.P. Morgan Healthcare Conference PR Newswire IRVINE, Calif., Jan. 3, 2017 IRVINE, Calif., Jan. 3, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring... More...>>
12/08/20167:00AMPRNUSEdwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference PR Newswire NEW YORK, Dec. 8, 2016 NEW YORK, Dec. 8, 2016  Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will discuss the company's strategy... More...>>
11/28/20166:00AMPRNUSEdwards Enters Into Agreement To Acquire Valtech Cardio
Edwards Enters Into Agreement To Acquire Valtech Cardio Additionally, Edwards Board Approves New $1 Billion Share Repurchase Program PR Newswire IRVINE, Calif., Nov. 28, 2016 IRVINE, Calif., Nov. 28, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for... More...>>
11/01/20169:40AMPRNUSEdwards Sapien Valves Demonstrate Excellent Durability In 5-Year Echo Study
Edwards Sapien Valves Demonstrate Excellent Durability In 5-Year Echo Study PR Newswire WASHINGTON, Nov. 1, 2016 WASHINGTON, Nov. 1, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced... More...>>
11/01/20169:20AMPRNUSEarly And Sustained Quality Of Life Improvements Seen For Intermediate Risk Patients Treated With Edwards Transcatheter Valve...
Early And Sustained Quality Of Life Improvements Seen For Intermediate Risk Patients Treated With Edwards Transcatheter Valves PR Newswire WASHINGTON, Nov. 1, 2016 WASHINGTON, Nov. 1, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart... More...>>
10/25/20169:40PMDJNEdwards Lifesciences Shares Fall After-Hours
Shares of Edwards Lifesciences Corp. fell sharply in after-hours trading Tuesday after the medical-device maker reported lower-than-expected sales of its minimally invasive heart valves in the third quarter. Sales of the company's Sapien heart valves grew 38.5% to $410.1 million in the quarter, lower than the $427.1... More...>>
10/25/20164:15PMPRNUSEdwards Lifesciences Reports Third Quarter Results
Edwards Lifesciences Reports Third Quarter Results PR Newswire IRVINE, Calif., Oct. 25, 2016 IRVINE, Calif., Oct. 25, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results... More...>>
10/12/201610:05AMPRNUSEdwards Lifesciences To Host Earnings Conference Call On October 25, 2016
Edwards Lifesciences To Host Earnings Conference Call On October 25, 2016 PR Newswire IRVINE, Calif., Oct. 12, 2016 IRVINE, Calif., Oct. 12, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans... More...>>
10/03/20161:00AMPRNUSEdwards Receives CE Mark For Hypotension Probability Indicator
Edwards Receives CE Mark For Hypotension Probability Indicator PR Newswire MILAN, Oct. 3, 2016 MILAN, Oct. 3, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received CE Mark... More...>>
10/03/20161:00AMPRNUSEdwards Receives CE Mark For Hypotension Probability Indicator
Edwards Receives CE Mark For Hypotension Probability Indicator PR Newswire MILAN, Oct. 3, 2016 MILAN, Oct. 3, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received CE Mark... More...>>
09/30/20169:00AMPRNUSThe Medical Device Industry's Focus on Cardio and Cardiovascular Needs
The Medical Device Industry's Focus on Cardio and Cardiovascular Needs PR Newswire NEW YORK, September 30, 2016 NEW YORK, September 30, 2016 /PRNewswire/ -- The medical devices market is very diverse, with devices that focus on various medical needs and procedures. On area where innovation is expected is the cardiac medical... More...>>
09/29/20168:30AMPRNUSEdwards INSPIRIS RESILIA Valve Receives CE Mark
Edwards INSPIRIS RESILIA Valve Receives CE Mark PR Newswire IRVINE, California, Sept. 29, 2016 IRVINE, California, Sept. 29, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received... More...>>
09/29/20168:30AMPRNUSEdwards INSPIRIS RESILIA Valve Receives CE Mark
Edwards INSPIRIS RESILIA Valve Receives CE Mark PR Newswire IRVINE, Calif., Sept. 29, 2016 IRVINE, Calif., Sept. 29, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V:us D:20170423 09:56:48